shared, there was a suggestion that patients might have
been under–dosed with the trial drugs. The high level
of data-completeness of correctly performed ACT tests,
together with the accurately recorded patient weights,
demonstrated that this was not the case. Importantly,
both for trial and present-day patients, adequate
anticoagulation in the emergency procedural phase
is ensured.